Hexagon Capital Partners »

Kymera Therapeutics shares owned by Hexagon Capital Partners

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Hexagon Capital Partners from 13F filings

Historical chart of Hexagon Capital Partners investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Hexagon Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Hexagon Capital Partners

Quarter filed Position value Share count Share price at filing
2025-03-31 $355 13 27.38
2024-12-31 $120 3 40.33

More positions owned by Hexagon Capital Partners

Walmart Stock (WMT)
Hunt J B Trans Svcs Stock (JBHT)
Meta Platforms Inc Cl A Stock (META)
Dillards Inc Cl A Stock (DDS)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Vanguard S&p 500 Etf Etf (VOO)
Enterprise Prods Partners Stock (EPD)
Vanguard Growth Etf Etf (VUG)
Vanguard Short-term Treasury Etf Etf (VGSH)
Vanguard Intermediate-term Treasury Etf Etf (VGIT)
Amazon Stock (AMZN)
Vanguard Value Etf Etf (VTV)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Vanguard Mid-cap Etf Etf (VO)

View all positions for Hexagon Capital Partners

Top funds holding Kymera Therapeutics

Baker Bros. Advisors
venBio Select Advisor
FMR
BVF
Vanguard Group
Wellington Management Company
Atlas Venture Life Science Advisors
BlackRock
Siren
State Street Corporation
Geode Capital Management
Capital Research Global Investors
Jennison Associates
Driehaus Capital Management
Ubs Global Asset Management Americas

View all funds holding Kymera Therapeutics